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A continuing study of a chemically induced model of "nephrosis" raises some
interesting possibilities in the understanding of membrane mechanochemistry
and resultant transport abnormalities.—Ed.

Effects of the Potent Neplirotogenic Aminonucleoside of
Puromycin on Pliospliolipid Metabolism in Rat Kidney
Cortex Subcellular Fractions '
Paul Bartlett, Ph.D.,** and James F. Bossart, M.S.t

Induction of the nephrotic syndrome in the rat with the aminonucleoside of
puromycin, 6-dimethylamino-9-(3'-amino-3'-deoxy-;8-D-ribofuranosyl)-purine, is accompanied by several significant alterations in enzymes and enzyme systems associated
with cellular bioenergetics,'"'' by striking alterations in glomerular and mitochondrial
membrane ultrastructure,^ by changes in mitochondrial mechanochemical parameters
such as swelling and U-factor formation,' and by significant reduction in the
phospholipid fraction of kidney total lipids.' During recent years a phospholipid requirement has been demonstrated for a variety of enzymatic activities closely associated
with the maintenance and function of cellular and membranous structures and particularly in the function of mitochondrial enzymes and enzyme systems associated with
cellular bioenergetics and membrane mechanochemistry.'""
Acting directly as a precursor of the phosphatidyl moiety in phosphatidyl inositol
(PI)'" and indirectly, through dephosphorylation catalyzed by phosphatidate phosphohydrolase (PA-Pase) (E.C.3.1.3.4.), as a precursor of the diglyceride moiety of
phosphatidyl choline (PC).'' phosphatidyl ethanolamine (PE)," and triglycerides,^
phosphatidic acid (PA) occupies a key position in the biosynthesis of phospholipids
(See Fig. 1). Thus situated, its metabolism, whether it involves entry into one of the
indicated metabolic pathways as a precursor of other phospholipids or participation
in a cyclic mechanism for the utilization of the energy of adenosine triphosphate
•Supported in part by PHS NIH Grant AM-06983 lo Paul Bartlett. Technical assistance ot Heidi
Schaefer in the PA-Pase assays is gratefully acknowledged. Miss Schaefer's current address is
2345 Post Street, San Francisco, California.
**Chairman, Department of Biochemistry and Molecular Biology, The Edsel B. Ford Institute for
Medical Research.
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(ATP) in the transport of hydrophilic substances across lipophilic membranes as
proposed by the Hokins'^"" may significantly affect membrane dynamics. In this
context, comparative studies of relative levels of PA-Pase activity in mitochondrial
and microsomal fractions and of ^'P-orthophosphate incorporation into the various
phosphatides of such fractions prepared from kidneys of normal rats and of aminonucleoside-nephrotic rats in which membrane transport is significantly altered were
undertaken with the hope that new insight into the pathogenesis of the aminonucleoside-induced disease and into normal membrane transport might be provided.
Methods
Sprague-Dawley virgin female rats, four to six months of age, maintained on
Rockland Rat Checkers (ad libitum feeding) were used in all studies. In experiments
in which the effects of induction of aminonucleoside-nephrosis on renal PA-Pase
were investigated, the rats were injected subcutaneously with 5 /xM aminonucleoside
per 100 gm body weight per day for a period of 10 days. Following the final
injection the animals were given no food for 24 hours and then sacrificed by stunning
and decapitation. In experiments in which ^'P-orthophosphate incorporation into the
various phospholipids was studied in normal and aminonucleoside-nephrotic rats, a
similar course of treatment with aminonucleoside was pursued and four hours prior
to sacrifice the animals were injected intraperitoneally with "P-orthophosphate solution,
pH 7.4, in doses of 200 /^C (microcuries) per 100 gm body weight. Specific activity
of the labeled compound was 200 p.C per p.M. The four-hour period was employed
to permit orthophosphate uptake on the ascending portion of the uptake curve."'''
Immediately following death, the kidneys were excised, decapsulated, and chilled in
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ice-cold 0.25 M sucrose. Mitochondria were prepared immediately from chilled
kidney cortex following the precautions described by Weinbach.^' The pellet was
sedimented at 3500 x g and washed 2 x with ice-cold 0.25 M sucrose. Microsomes
were sedimented from the mitochondrial pellet supernatant by centrifugation at
54,000 X g.
Preparation and assay of deoxycholate extracts of mitochondria and microsomes
for PA-Pase activity were accomplished as described by Hokin and Hokin." All
extracts were dialyzed for 16 hours in the cold room at 3-5°C. to reduce orthophosphate
blanks to a minimum. Substrate phosphatidic acid was synthesized essentially as
described by Baer and Buchnea,^" purified on silicic acid columns^' and used as the
sodium salt. Diolein used in the synthesis was a commercial preparation (D47-DO)
supplied through the courtesy of Distillation Products Industries and contained 70%
1,3-diolein and 30% 1,2-diolein." PA-Pase activities expressed in terms of n\p.M
orthophosphate released per hour per milligram extract protein were in all experiments
blank corrected. Blanks were run not only on reaction mixtures minus substrate but
also on reaction mixtures minus extract.
In experiments in which the incorporation of ^^P-orthophosphate into the various
phosphatides was studied, the phospholipids were extracted from subcellular fractions
as described by Biezenski and Spaet.'^ Non-lipid contaminants were removed from
the extracts by eluting aliquots of the phospholipid extracts from silicic acid-impregnated paper with methanol-chloroform (20:80) as described by Biezenski." The
purified extracts were resolved by thin-layer chromatography on basic plates of silica
gel G " or by 2-dimensional thin-layer chromatography (TLC) as described by
Abramson and Blecher." The resolved phosphatides were visualized by exposure of
the TLCs to iodine vapor, the spots outlined, removed from the plates, and extracted
with acidified 3 N methanol. Extracts were evaporated to dryness and phosphorus
determined on the residues by the Marinetti modification of the Bartlett procedure."
^^P activity was determined on similariy resolved fractions of the purified extracts by
removing the silica gel G spots from the plate and resuspending the material directly
in the solvent system described by Kinard^' containing 4% by weight Thixotropic
Gel Powder (Cab-O-Sil). Samples were counted with an efficiency of 85% in a
Tri-Carb 314 x Scintillation Spectrometer. A l l counts were corrected for decay and
quenching by use of an internal standard.
Results
Table I summarizes the results of PA-Pase studies on deoxycholate extracts of
mitochondrial and microsomal fractions prepared from the kidneys of nine groups
of normal rats and six groups of aminonucleoside-nephrotic rats (two rats per group).
Clearly the PA-Pase activity in such fractions is significantly increased in rats in which
the nephrotic syndrome has been induced with the aminonucleoside. Attempts to
assess the in vHro effects of aminonucleoside on PA-Pase activity of deoxycholate
extracts of normal rat kidney mitochondrial and microsomal fractions have thus far
yielded information of dubious significance. Relatively high concentrations of amin139
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TABLE I
PA-Pase ACTIVITY OF DE05CYCH0LATE EXTRACTS OF KIDNEY CORTEX
MITOCHONDRIA AND MICROSOMES
muM Orthophosphate Released/hr/mg Extract Protein
Mitochondria
Normals ( 9 ) *

378 + 158

Microsomes
365 ± 67

(104 - ei?)"*"

(290 - 477)

Nephrotic (6)

668 + 96
(498 - 799)

505 ± 55
(446 - 579)

P* (reference 45)

< 0.01

< o.Ol

*

Pairs of rats studied,

t

Range of values,

±

Values are standard deviations.

*

P = Significance of difference of mean PA-Pase
a c t i v i t i e s for nephrotic and normal r a t s .

onucleoside (10-20 m M ) though appearing to inhibit PA-Pase activity also stimulated
to a striking degree the release of orthophosphate from deoxycholate extract controls
assayed in the absence of phosphatidate. Though interesting, this finding still remains
unexplained and until more relevant information becomes available, decision concerning direct versus indirect effects of aminonucleoside on PA-Pase activity must
necessarily be held in abeyance.
Employing experimental conditions identical to those utilized in the assay of
PA-Pase activity but with a- or yS-glycerophosphate substrate substituted for phosphatidate the possibility of the existence of an alternative mechanism of dephosphorylation
of the latter by deoxycholate extracts has also been investigated. Sequential deacylation of phosphatidate to glycerophosphate followed by phosphomonoesterase catalyzed
dephosphorylation of the latter, for example, would constitute such a mechanism.
Although the results of such studies, shown in Table I I , cleariy indicate the presence
of considerable phosphomonoesterase activity in deoxycholate extracts of normal rat
kidney mitochondrial and microsomal fractions, such activity remains relatively unaffected as a result of induction of aminonucleoside-nephrosis in the rat, whereas
PA-Pase activity is virtually doubled. Moreover failure to obtain any evidence for
the release of fatty acid ester groups from PA by hydroxaminolysis and spectrophotometric determination of ferric hydroxamate complexes during incubation periods
comparable to those employed in the PA-Pase assays further substantiates the conclusion that we are, indeed, assaying PA-Pase activity and not the suggested alternative
dephosphorylation process.
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TABLE H
NONSPECIFIC PHOSPHOMONOESTERASE ACTIVITY OF DEOXYCHOLATE EXTRACTS OF KIDNEY
MITOCHONDRIA AND MICROSOMES
Orthophosphate Released mtiM/hr/mg Extract Protein
Substrate*

Aroinomucleoside-Nephrotic
Rat Kidney
Mitochondria Microsomes

Normal Rat Kidney
Mitochondria Microsomes

a-Glycerophosphate

240

98

190

92

^-Glycerophosphate

707

375

871

386

*

Substrate concentration 0.002 M i n a l l

experiments.

Table 111 shows the distribution of ^^P-orthophosphate incorporated into the
phospholipids of mitochondrial and microsomal fractions prepared from the kidney
cortex of both normal and aminonucleoside-nephrotic rats. Certainly the most striking
alteration seen in this data is in the percentage of the total "P incorporated into the
PI fraction. In aminonucleoside-nephrotic rats this percentage is almost double that
seen in normal rats.
TABLE I I I
DISTRIBUTION OF ^^P-ORTHOPHOSPHATE INCORPORATED INTO KIDNEY CORTEX PHOSPHOLIPIDS*
Percentage of Total 32p Incorporated i n t o Phospholipid
Phospholipid
Fraction

*

Normal Rat Kidney
Mitochondria Microsomes

Aminonucleoside-Nephrotic Rat Kidney
Mitochondria Microsomes

PC

73.53

79.75

70.39

72.68

PE

14.34

9.09

14.01

12.67

PI

6.05

5.72

11.94

10.91

PA

1.69

2.34

1.46

1.70

Sph

2.94

1.48

2.10

1.86

Phosphatidyl serine (PS) was not detected on the TLCs.

Tables I V and V summarize specific activity and relative specific activity data
for the several phospholipids isolated from kidney cortex mitochondria and microsomes
of normal and aminonucleoside-nephrotic rats. Specific activity of kidney mitochondrial PC is reduced 11 % as a result of induction of aminonucleoside-nephrosis in the
rat. Specific activities of the PI and PE fractions, on the other hand, are increased
9 and 35% respectively in aminonucleoside-nephrotic rat kidney mitochondria. Specific
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TABLE IV
SPECIFIC ACTIVITY AND RELATIVE SPECIFIC ACTIVITY OF RAT KIDNEY CORTEX
MITOCHONDRIAL PHOSPHOLIPIDS

Phospholipid
Fraction

Specific A c t i v i t y
(CPM/ ugm.P)

Normal

AminonucleosideNephrotic

Relative Specific A c t i v i t y *
(x 10)

Normal

AminonucleosideNephrotic

PC

7,031

6,256

9.3

6.3

PI

4,822

5,255

6.3

5.3

Pi;

1,714

2,313

2.3

2.3

PA

758

746

1.0

0.7

Sph

681

713

0.9

0.8

J. „ 1 ... _
, ... . _
* Relative Specific A c t i v i t y

Specific A c t i v i t y of Phospholipid-P
= -r^ — — — — — f
——./^,^
Specific A c t i v i t y of Acid-Soluble-P

activities of PA and Sph (sphingomyelin) fractions remain unchanged. Relative
specific activities of the PC, PI, and PE fractions were reduced respectively 32, 15,
and 0% while that of the PA fraction was decreased 30% in mitochondria.
TABLE V
SPECIFIC ACTIVITY AND RELATIVE SPECIFIC ACTIVITY OF RAT KIDNEY CORTEX
MICROSOMAL PHOSPHOLIPIDS
Phospholipid
Fraction

*

Specific A c t i v i t y
(CPM/ugm.P)

Relative Specific A c t i v i t y *
(x 10)

Normal

AminonucleosideNephrotic

Norma 1

AminonucleosideNephrotic

PC

4,829

4,861

6.6

4.9

PI

2,508

3,306

3.4

3.3

PE

1,720

2,331

2.3

2.4

PA

381

694

0.5

0.7

Sph

392

337

0.5

0.3

See footnote i n Table IV.
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In the case of kidney microsomal fractions, induction of aminonucleoside-disease
had no effect on the specific activity of the PC fraction but produced marked and
striking elevations in the specific activities of the PI, PE, and PA fractions. These
were respectively 32, 35, and 82% higher in the fractions prepared from aminonucleoside-nephrotic rat kidney microsomes. Relative specific activities remained unchanged
in PI and PE fractions, increased 40% in the PA fraction, and decreased 26% in
the PC fraction as a result of induction of the aminonucleoside disease.
Discussion
The striking increase in PA-Pase activity in deoxycholate extracts of kidney
mitochondria and microsomes of rats treated with the aminonucleoside of puromycin
and the apparent inhibition of such activity in extracts prepared from normal rat
kidney subcellular fractions assayed in the presence of added aminonucleoside bears
a striking resemblance to previously reported effects of aminonucleoside on ATPase
activity.^' Thus, both PA-Pase and ATPase activity are significantly elevated in
aminonucleoside-nephrotic rat kidney mitochondrial and microsomal fractions and
paradoxically both appear to be inhibited in assays conducted in the presence of
added aminonucleoside. To some degree, as earlier reported, the inhibitory effects
of aminonucleoside on the ATPase activity of rat kidney cortex mitochondria appear
to be dependent on the presence of exogenously added activating cations and/or on
the structural state of the mitochondria." Indeed, ATPase activity assayed in the
absence of exogenously added activating cations, but in the presence of added aminonucleoside was actually stimulated." In the absence of experimental information pertaining to the effects of ionic environment on PA-Pase activity of deoxycholate
extracts of kidney mitochondrial and microsomal fractions, we can only speculate
concerning a similar dependency. Relatively recent studies of partially purified soluble
rat liver phosphatidate phosphohydrolase activity, however, indicate stimulation of
such activity by monovalent cations such as Na+ and K+.*' So, it is tempting to
speculate that in this respect also the PA-Pase and ATPase activities of kidney
mitochondrial and microsomal fractions are also strikingly similar, and that similar
phosphohydrolase-aminonucleoside interaction sites are probably involved in the observed alterations.
Since increased PA-Pase activity might be expected to enhance the pool of
diglyceride precursors available for the formation of PC, PE, and triglycerides, stimulation of the formation of these lipids might also be expected. As judged by relative
specific activity data, biosynthesis of PC is actually reduced, contributing to the
reduction of kidney total phospholipids in the aminonucleoside-nephrotic rat as reported
by Levy.' Biosynthesis of PE was not affected. Marked hyperlipemia in aminonucleoside-nephrotic rats to which a several-fold increase in serum triglycerides is a major
contributing factor' might, however, be at least partially ascribable to the stimulating
effect of increased diglycerides on triglyceride formation.
Acting directly as a precursor of the phosphatidyl moiety in the biosynthesis
of P I , " PA might be expected to be more highly labeled with ^'P than PI. Data
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presented in Tables I V and V, however, clearly indicate that the opposite situation
prevails. In both rat kidney cortex mitochondrial and microsomal fractions of normal
and of aminonucleoside-nephrotic rats, the specific activity and the relative specific
activity of the PI fraction are five- to seven-fold greater than the corresponding values
for the PA fraction. Our findings in rat kidney cortex subcellular fractions are in
this respect strikingly similar to those reported by Tinker et aF in studies on phospholipid metabolism in rabbit kidney cortex slices. The relatively low level of labeling
of PA in comparison with that of PI is difficult to explain in terms of a metabolite
pathway involving random metabolism of precursor molecules.'" Existence of an
alternative metabolic pathway for the formation of PI, utilization of compartmentalized
PA," or selective uptake of newly synthesized radioactive PA for PI formation
(equivalent to nonrandom utilization of PA as suggested by Possmayer and Strickland")
might be invoked, however, to explain these observations. Possmayer and Strickland"
in studying the nature of the cytosine nucleotide requirement for the biosynthesis of
PI in rat brain have reported PA biosynthesis to be inhibited by cytidine triphosphate
(CTP) or some product derived therefrom. Results of their studies indicated the
labeling of PA from a-glycerophosphate to be substantially reduced in the presence
of CTP but labeling of PI to be enhanced and above that in the PA fraction. Should
it prove possible to demonstrate similar effects of CTP on the labeling of the same
phosphatides in kidney tissue the observed differences in the labeling of PA and PI
might be similarly explained.
As to the significance of the striking alterations induced in phospholipid metabolism in kidney cortex mitochondria and microsomes as a result of induction of the
nephrotic syndrome in the rat with the aminonucleoside of puromycin we can only
speculate at this time. Clearly, however, under experimental conditions (i.e., induction
of the nephrotic syndrome) known to be accompanied by profound alterations in
glomerular membrane permeability to albumin and in tubular water and electrolyte
transport, shifts in the metabolic activity of PC, PI, PE, and PA focus attention
again on the possible involvement of phospholipids in membrane mechanochemistry.
In this context the findings of Vignais et al," that PI is a required factor for ATPinduced contraction of pre-aged or KCl-extracted rat liver mitochondria and the
recently reported observations of Martonosi et al " on the role of phospholipids and especially of lecithin (PC) and lysolecithin in the ATPase activity and Ca++ transport of
sarcoplasmic reticulum and on kidney microsomal ATPase isolated as described by
Skou,'*'' may in some as yet unknown manner be relevant. Thus far, the preponderance
of experimental information available does not appear to support direct participation
of phospholipids as phosphorylated intermediates in the reactions of cellular bioenergetics. Alternatively their involvement may well prove to be relatable to a
physical role in specific tertiary or quaternary conformation of membrane proteins.
Increasing tempo of investigations focusing on this aspect of phospholipid involvement
in membrane mechanochemistry will hopefully provide new insight into what might
be classified as membrane transport abnormalities.
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